Home/Accutar Biotechnology/Xiangyan Sun, MS
XS

Xiangyan Sun, MS

Chief Technology Officer

Accutar Biotechnology

Therapeutic Areas

Accutar Biotechnology Pipeline

DrugIndicationPhase
AC699ER+/HER2-, ESR1-mutated advanced or metastatic breast cancerPhase 1